Positive scientific opinion by EMA would create pathway for arpraziquantel in African endemic countries
News
Healthcare leaders warn about unsustainable pressure on mental health services
Patients and service users routinely struggle to access mental healthcare across the NHS
Valneva and Pfizer report Lyme disease antibody data
Children and adults have been treated using the Lyme disease antibody candidate VLA15
Respiratory vaccination candidate tested in German hospitals
Novel tuberculosis vaccine tested in a large phase 3 trial against severe respiratory infection disease
Eisai and Biogen present promising lecanemab study results
Phase 3 research shows that Alzheimer’s disease treatment meets primary and secondary endpoints
Otsuka receives vital Lupkynis MHRA authorisation
Therapy represents first oral calcineurin-inhibitor treatment for active lupus nephritis in adults
Touchlight receives funding to develeop DNA vaccine platform
Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA
Immutep in clinical trail collaboration with Merck KGaA and Pfizer
Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer
Almirall joins project to allow study participants to use trial data
Project involves 27 partners including patient associations, hospitals and universities
C4XD signs NRF2 Activator deal with AstraZeneca
C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial
Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation
Treatment involves adults with certain forms of advanced stomach and oesophageal cancer
Depressive therapy Spravato demonstrates superior efficacy
Research supports use of Spravato nasal spray in adults with major depressive disorder
Storm doses first patient with solid tumour drug candidate
Candidate is first molecule targeting an RNA methyltransferase enzyme to enter development
Multi-drug precision medicine cancer trial begins
Patients on the trial will have one of the particular genetic mutations among rare cancers
Study brings personalised immunotherapy prescriptions closer
Research showed that prescribing based solely on levels of proteins present is unlikely to be suitable
